What Is the FDA - Search News

FDA will lift warnings on hormone therapy for menopause

FDA removes the black box warning on hormone therapy for menopause

Now the Food and Drug Administration is asking drug companies to remove these labels, known as black box warnings, on hormone therapy drugs containing estrogen. This change will be monumental in helping more women manage disruptive menopause and perimenopause symptoms ranging from increased urinary tract infections to night sweats.

· 14h · on MSN

FDA chief says warning labels deterred women from using menopause hormone therapy: "It's an American tragedy"

· 7h · on MSN

FDA moves to lift ‘black box’ warnings from hormone therapies for menopause symptoms

· 4h

FDA reverses decades of guidance on hormone therapy for menopause

The FDA is removing the black box warning on estrogen therapy after two decades.

· 5h

The FDA removes a long-standing warning from hormone-based menopause drugs

· 7h

FDA to remove box warnings off of hormone therapies for menopause

· 10h

‘Black box’ safety warning to be removed from hormone therapy for menopause

After the study and the label change, doctors became reluctant to prescribe them and prescriptions for hormone therapy for menopause dropped by more than 70%.

KSL · 5h

FDA to drop black box warnings from menopause hormone therapies

· 9h

FDA to remove ‘black box’ warning from menopause hormone therapy

CT Insider on MSN

FDA announces recall of common ADHD drug prescribed in Connecticut and nationwide

Taking the recalled drugs could cause "temporary or medically reversible adverse health consequences," under a Class II recall.

Earth.com

Is bottled water safe to drink? Here's what the FDA says after its latest round of testing

The U.S. Food and Drug Administration (FDA) tested bottled waters for PFAS forever chemicals, randomly selecting them from U.S. store shelves. Samples were collected in 2023 and 2024 across retail stores nationwide. They covered purified, spring, artesian, and mineral waters.

Fierce Pharma

PreCheck pulse check: What the industry is saying about FDA’s production initiative

As the prospect of import tariffs and drug price reform marshals billions of biopharma investment dollars into the U.S., the feasibility of rapid domestic manufac | This week on “The Top Line,” we break down what’s known about FDA’s PreCheck,

FOX News on MSN

FDA commissioner explains what he says 2002 Women's Health Initiative study got wrong.mp4

FDA Commissioner Dr. Marty Makary makes an announcement about his agency’s intent to remove the “black box” warnings from hormone replacement therapy for menopause.

6don MSNOpinion

What the FDA’s latest scandal says about Marty Makary’s leadership

The latest turmoil within Commissioner Marty Makary’s Food and Drug Administration, an alleged bribery scandal involving a high-level official, is no anomaly. The Sunday resignation of the Center for Drug Evaluation and Research’s Dr.

FDA Blood Pressure Med Recall—What to Know Right Now

The Food and Drug Administration (FDA) just announced that over 580,000 bottles of blood pressure medications made by Teva Pharmaceuticals USA and distributed by Amerisource Health Services have been recalled after it was discovered that they might contain a cancer-causing chemical.

STAT

What’s FDA plotting for therapy chatbot regulation?

The Food and Drug Administration is considering whether and how to regulate therapy chatbots that are based on large language models. Today, the agency’s Digital Health Advisory Committee is meeting to consider the topic. In a new story, I explain what’s going on, including some fresh insider intel.